Stocks
CAMP4 THERAPEUTICS CORPORATIONCAMP
NASDAQHealthcareBiotechnology$4.75
A clinical-stage biotechnology company developing RNA-based therapeutics designed to upregulate gene expression for the treatment of genetic diseases. Its platform targets regulatory regions of DNA to increase production of beneficial proteins, an approach aimed at conditions caused by insufficient ...
52W Range: $1.30 – $7.75
Congressional Interest in CAMP4 THERAPEUTICS CORPORATION (CAMP)
1 member of Congress has disclosed 1 trade in CAMP4 THERAPEUTICS CORPORATION (CAMP), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CAMP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-22 | MICHAEL T. MCCAUL | buy | $1K – $15K |